Skip to main content
. 2018 Mar 2;26(4):963–975. doi: 10.1016/j.ymthe.2018.01.020

Figure 4.

Figure 4

Superior Anti-tumor Activity from 4-1BB CAR T Cells Was Measured by Long-Term Killing Assay

(A) Diagram of experimental design for long-term killing assay. (B and C) Anti-tumor effects of Kappa-CAR (B) and CD19-CAR (C) were measured by the decrease in tumor cell number (left) and increase in effector cell number (right). A Kappa-positive Daudi cell expressing fluorescent protein mCherry was used as a target cell. (B and C) Error bars show ± SD.